At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Jun 9, 2026 at 17:40 ET
A cluster of insider selling at Neurocrine Biosciences over the past week totals $4.53M in open-market sales by four officers/directors, including the Chief Scientific Officer and Chief Human Resources Officer. The selling is modest relative to the $16.4B market cap (0.028%) and includes non-cash derivative exercises and gifts, suggesting liquidity-driven rather than informational selling.
- Four insiders sold a total of $4.53M in open-market sales over 7 days (May 29–June 5, 2026).
- Sales represent ~0.028% of NBIX's $16.4B market cap, well below the 0.1% materiality threshold.
- Director Sherwin exercised 30,000 options (non-cash) and sold 7,883 shares for $1.29M; the exercise price was $53.64, indicating routine option monetization.
- Chief Scientific Officer Onyia gifted 2,441 shares (non-cash), no economic signal.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access